Literature DB >> 14713729

Stem cells for the heart, are we there yet?

F Timmermans1, J De Sutter, T C Gillebert.   

Abstract

Although several repair mechanisms have been described in the human heart, all fall too short to prevent clinical heart disease in most acute or chronic pathological cardiac conditions. Moreover, despite many breakthroughs in cardiovascular medicine, the complications of a myocardial infarction such as chronic heart failure remains a serious worldwide problem. Bone marrow stem cells could provide for a promising strategy to restore myocardial infarctions and prevent postinfarct congestive heart failure, because there is growing body of evidence that bone marrow stem cells, such as mesenchymal stem cells, can generate new cardiomyocytes in animals and humans. In this review, we will discuss important issues on stem cell therapy for cardiac regeneration after myocardial infarction, which might be of paramount importance when considering future human trials. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14713729     DOI: 10.1159/000074811

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  5 in total

1.  Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.

Authors:  Ba-Khoi Nguyen; Simon Maltais; Louis P Perrault; Jean-François Tanguay; Jean-Claude Tardif; Louis-Mathieu Stevens; Mélanie Borie; François Harel; Samer Mansour; Nicolas Noiseux
Journal:  J Cardiovasc Transl Res       Date:  2010-02-26       Impact factor: 4.132

2.  Quantitative imaging of myocardial infarct in rats with high resolution pinhole SPECT.

Authors:  Paul D Acton; Daniel Thomas; Rong Zhou
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-04       Impact factor: 2.357

3.  Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential.

Authors:  Tom J Burdon; Arghya Paul; Nicolas Noiseux; Satya Prakash; Dominique Shum-Tim
Journal:  Bone Marrow Res       Date:  2010-12-06

4.  One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133 Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction.

Authors:  Samer Mansour; Denis-Claude Roy; Vincent Bouchard; Louis Mathieu Stevens; Francois Gobeil; Alain Rivard; Guy Leclerc; François Reeves; Nicolas Noiseux
Journal:  Bone Marrow Res       Date:  2011-02-27

5.  Secreted factors from adipose tissue-derived mesenchymal stem cells suppress oxygen/glucose deprivation-induced cardiomyocyte cell death via furin/PCSK-like enzyme activity.

Authors:  Yuki Tachida; Koji Suda; Hiroyuki Nagase; Kohei Shimada; Fujio Isono; Hideki Kobayashi
Journal:  Biochem Biophys Rep       Date:  2016-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.